Navigation Links
Nasal polyps from analgesics
Date:3/10/2008

If a patient develops respiratory problems after taking analgesics, this indicates that the active substances are poorly tolerated. This is pointed out by Prof. Hanns-Wolf Baenkler, Erlangen University Medical School, in the current edition of the Deutsches rzteblatt International (Dtsch Arztebl Int 2008; 105(8): 13742). One should also think of analgesic intolerance when patients suffer from chronic irritation of the gastrointestinal tract, without any recognizable allergy or infection.

Patients with these symptoms exhibit enhanced sensitivity and changes in the pattern of the so-called eicosanoids - important mediators of pain and inflammation. This change in pattern explains the specific reaction to salicylates and related COX inhibitors in analgesics, cosmetics, and vegetable foods. The classical symptoms of intolerance are rhinitis, bronchial asthma or nasal polyps, accompanied by inflammatory reactions in the intestine or skin and urticaria.

The diagnosis is based on symptoms immediately after taking salicylates or on recurrent polyp formation. Blood tests can be an important diagnostic aid, particularly in difficult cases. Discontinuation of treatment helps, as does corticosteroid treatment. Biological treatment is also possible, based on adaptation by administering increasing doses of acetylsalicylic acid.


'/>"/>

Contact: Dr. Stephan Mertens
stephan.mertens@aerzteblatt.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Saline Nasal Wash Helps Kids Fight Colds, Flu
2. Protein Nasal Spray Revives Sleep-Deprived Monkeys
3. Saline Irrigation Eases Chronic Nasal Symptoms
4. New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis
5. U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children
6. As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines
7. Nosefrida Nasal Aspirator - A Parents Alternative to Medicines on the Verge of FDA Ban
8. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
9. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
10. Nasal Anthrax Vaccine Proves Effective in Animal Study
11. Smoking can double risk of colorectal polyps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/4/2017)... Oct. 4, 2017 OBP Medical ... illuminating medical devices, today announced regulatory approval from ... Agency (or Agência Nacional de Vigilância Sanitária (ANVISA)) ... cordless surgical retractor with integrated LED light source ... illumination and exposure of a tissue pocket or ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology: